cytarabine has been researched along with Myasthenia Gravis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukui, T; Goto, M; Hakiri, S; Hashimoto, K; Ito, T; Kawaguchi, K; Mori, S; Nakamura, S; Ozeki, N; Yokoi, K | 1 |
| Hawkey, CJ; Newsom-Davis, J; Vincent, A | 1 |
| Cendrowski, W; Riekkinen, PJ; Rinne, UK | 1 |
1 review(s) available for cytarabine and Myasthenia Gravis
| Article | Year |
|---|---|
Immunosuppressive therapy in neurological diseases.
Topics: Adrenocorticotropic Hormone; Azathioprine; Central Nervous System Diseases; Cyclophosphamide; Cytarabine; Encephalitis; Female; Humans; Hydrocortisone; Immunity, Cellular; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymphocyte Activation; Methotrexate; Multiple Sclerosis; Myasthenia Gravis; Myositis; Neuritis; Polyradiculopathy; Prednisone; Virus Diseases | 1974 |
2 other study(ies) available for cytarabine and Myasthenia Gravis
| Article | Year |
|---|---|
Multimodality therapy for thymoma patients with pleural dissemination.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Female; Humans; Induction Chemotherapy; Lomustine; Male; Middle Aged; Mitoxantrone; Myasthenia Gravis; Neoplasm Recurrence, Local; Pleural Diseases; Pneumonectomy; Prednisone; Retrospective Studies; Survival Rate; Thymoma; Thymus Neoplasms | 2019 |
Plasma exchange and immunosuppressive drug treatment in myasthenia gravis: no evidence for synergy.
Topics: Adolescent; Adult; Aged; Autoantibodies; Azathioprine; Cyclophosphamide; Cytarabine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myasthenia Gravis; Plasma Exchange; Receptors, Cholinergic | 1981 |